Baidu
map

心血管

订阅

MedSci主页 / 所有栏目 / 心血管

JAMA：美国心脏病学会/美国心脏学会临床实践指南Ⅰ类建议的耐用性

2014-06-16 马克·D ·纽曼等 美国费城宾夕法尼亚大学佩雷尔曼医学院麻醉 中国医学论坛报JAMA专版

美国心脏学会临床实践指南Ⅰ类建议耐用性
关注

意义：对于临床实践指南随时间延长的耐用性尚知之甚少。目的：了解美国心脏病学会/美国心脏学会(ACC/AHA)临床实践指南Ⅰ类建议(应当实施/采用的操作/治疗)耐用性发生变化的特征。　 设计、场所和参与者：由4个独立的评审人对1998-2007年期间发布、2006-2013年期间修订的11部指南进行文本分析。 主要转归和检测指标：我们(找出)每部指南最近的2个版本，摘选第一个版本

意义：对于临床实践指南随时间延长的耐用性尚知之甚少。【原文下载】 目的：了解美国心脏病学会/美国心脏学会(ACC/AHA)临床实践指南Ⅰ类建议(应当实施/采用的操作/治疗)耐用性发生变化的特征。   设计、场所和参与者：由4个独立的评审人对1998-2007年期间发布、2006-2013年期间修订的11部指南进行文本分析。   主要转归和检测指标：我们(找出)每部指南最近的2个版本，摘选第一个版本中所有的一类建议，并在随后版本中找到相应的建议。我们对建议进行分类，对于被不太确定或相反建议取代的建议，我们将其归类为建议降级或逆转，而对于(随后的版本中)找不到相应条目的建议，我们将其归类为建议被省略。我们采用双变量模型假设检验和条件罗杰斯谛回归法，并根据指南主题和基础证据水平，来检验建议耐用性的差异。 （点击可放大） 结果：在619条索引建议中，有495条(80.0%，95%CI为76.6%～83.1%)在随后的指南版本中得以保留，有57条(9.2%，95%CI为7.0%～11.8%)被降级或逆转，有67条(10.8%，95%CI为8.4%～13.3%)被省略。在

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2030976, encodeId=486520309e6f0, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Jun 24 09:19:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807564, encodeId=03f9180e56465, content=<a href='/topic/show?id=e1718036577' target=_blank style='color:#2F92EE;'>#耐用性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80365, encryptionId=e1718036577, topicName=耐用性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Sep 10 11:19:00 CST 2014, time=2014-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018550, encodeId=9718201855074, content=<a href='/topic/show?id=ff3c51599b0' target=_blank style='color:#2F92EE;'>#心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51599, encryptionId=ff3c51599b0, topicName=心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Tue Sep 02 12:19:00 CST 2014, time=2014-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323598, encodeId=da8113235986c, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Wed Jun 18 04:19:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571925, encodeId=fca615e1925f2, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Wed Jun 18 04:19:00 CST 2014, time=2014-06-18, status=1, ipAttribution=)]
    2014-06-24 lvliquan

    #实践指南#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2030976, encodeId=486520309e6f0, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Jun 24 09:19:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807564, encodeId=03f9180e56465, content=<a href='/topic/show?id=e1718036577' target=_blank style='color:#2F92EE;'>#耐用性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80365, encryptionId=e1718036577, topicName=耐用性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Sep 10 11:19:00 CST 2014, time=2014-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018550, encodeId=9718201855074, content=<a href='/topic/show?id=ff3c51599b0' target=_blank style='color:#2F92EE;'>#心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51599, encryptionId=ff3c51599b0, topicName=心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Tue Sep 02 12:19:00 CST 2014, time=2014-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323598, encodeId=da8113235986c, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Wed Jun 18 04:19:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571925, encodeId=fca615e1925f2, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Wed Jun 18 04:19:00 CST 2014, time=2014-06-18, status=1, ipAttribution=)]
    2014-09-10 doctorzheng

    #耐用性#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2030976, encodeId=486520309e6f0, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Jun 24 09:19:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807564, encodeId=03f9180e56465, content=<a href='/topic/show?id=e1718036577' target=_blank style='color:#2F92EE;'>#耐用性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80365, encryptionId=e1718036577, topicName=耐用性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Sep 10 11:19:00 CST 2014, time=2014-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018550, encodeId=9718201855074, content=<a href='/topic/show?id=ff3c51599b0' target=_blank style='color:#2F92EE;'>#心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51599, encryptionId=ff3c51599b0, topicName=心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Tue Sep 02 12:19:00 CST 2014, time=2014-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323598, encodeId=da8113235986c, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Wed Jun 18 04:19:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571925, encodeId=fca615e1925f2, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Wed Jun 18 04:19:00 CST 2014, time=2014-06-18, status=1, ipAttribution=)]
    2014-09-02 qblt

    #心脏病学#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2030976, encodeId=486520309e6f0, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Jun 24 09:19:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807564, encodeId=03f9180e56465, content=<a href='/topic/show?id=e1718036577' target=_blank style='color:#2F92EE;'>#耐用性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80365, encryptionId=e1718036577, topicName=耐用性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Sep 10 11:19:00 CST 2014, time=2014-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018550, encodeId=9718201855074, content=<a href='/topic/show?id=ff3c51599b0' target=_blank style='color:#2F92EE;'>#心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51599, encryptionId=ff3c51599b0, topicName=心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Tue Sep 02 12:19:00 CST 2014, time=2014-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323598, encodeId=da8113235986c, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Wed Jun 18 04:19:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571925, encodeId=fca615e1925f2, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Wed Jun 18 04:19:00 CST 2014, time=2014-06-18, status=1, ipAttribution=)]
    2014-06-18 yanjie6253_56072842

    #临床实践#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2030976, encodeId=486520309e6f0, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Jun 24 09:19:00 CST 2014, time=2014-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807564, encodeId=03f9180e56465, content=<a href='/topic/show?id=e1718036577' target=_blank style='color:#2F92EE;'>#耐用性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80365, encryptionId=e1718036577, topicName=耐用性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Sep 10 11:19:00 CST 2014, time=2014-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018550, encodeId=9718201855074, content=<a href='/topic/show?id=ff3c51599b0' target=_blank style='color:#2F92EE;'>#心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51599, encryptionId=ff3c51599b0, topicName=心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Tue Sep 02 12:19:00 CST 2014, time=2014-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323598, encodeId=da8113235986c, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Wed Jun 18 04:19:00 CST 2014, time=2014-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571925, encodeId=fca615e1925f2, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Wed Jun 18 04:19:00 CST 2014, time=2014-06-18, status=1, ipAttribution=)]
    2014-06-18 lily1621

    #临床实践指南#

    0

相关资讯

AHA2012科学年会：治疗儿童咽喉痛预防风湿热有成本效益并可挽救生命

　　一项统计学分析表明，在发展中国家，通过一次性注射青霉素治疗发生咽喉痛的儿童来预防少数人发生急性风湿热和风湿性心脏病的策略具有成本效益并可挽救生命。该分析于11月4日在美国心脏学会（AHA）2012科学年会报告。 　　风湿性心脏病是急性风湿热的最严重后遗症，是由A组链球菌属（GAS）引发，通常始于咽炎。风湿热在工业化国家极罕见，但在发展中国家仍是一个严重问题。通过对咽喉痛患儿一次性注射青霉素，

AHA发布2013心脏病和卒中统计报告

　　每年，美国心脏学会（AHA）都会联合美国疾病预防控制中心、国立卫生研究院及其他政府机构对心脏病、卒中、其他血管病及其危险因素进行统计并发布更新报告。自1999年以来，这些统计报告已被文献引用超过10500次。近年来，统计更新已发生了很多变化，加入了新的章节并在多个领域有重要更新。该报告2012年12月12日在线发表于《循环》（Circulation）杂志。 　　2013版更新将统计数据扩展至

新指南：替卡瑞洛定为UA一线治疗药

       Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina           美国心脏病学会基金会（ACCF）/美

AHA2012科学年会：治疗儿童咽喉痛预防风湿热

　　一项统计学分析表明，在发展中国家，通过一次性注射青霉素治疗发生咽喉痛的儿童来预防少数人发生急性风湿热和风湿性心脏病的策略具有成本效益并可挽救生命。该分析于11月4日在美国心脏学会（AHA）2012科学年会报告。 　　风湿性心脏病是急性风湿热的最严重后遗症，是由A组链球菌属（GAS）引发，通常始于咽炎。风湿热在工业化国家极罕见，但在发展中国家仍是一个严重问题。通过对咽喉痛患儿一次性注射青霉素，

AHA2012科学年会：心梗螯合疗法益处令人疑惑

　　美国西奈山医学中心的Gervasio A Lamas在美国心脏学会（AHA）2012科学年会报告了螯合疗法评估试验（TACT）结果，这项随机、双盲试验提示，一种替代性医疗支持可能适度改善急性心肌梗死后患者的临床转归，结果使人产生困惑。 　　研究者使用一种费力的治疗方案，对患者进行40次每次3小时输注成分复杂的标准螯合治疗液，随访4年，与安慰剂相比，试验的主要终点降低了18

Baidu
map
Baidu
map
Baidu
map